- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x CA: CALCIUM ION(Non-covalent)
- 4 x ZMR: ZANAMIVIR(Non-covalent)
ZMR.5: 16 residues within 4Å:- Chain A: R.116, E.117, D.149, R.150, R.154, W.177, I.221, R.223, E.226, A.245, E.275, E.276, R.292, N.294, R.374, Y.409
23 PLIP interactions:23 interactions with chain A- Hydrophobic interactions: A:W.177, A:I.221, A:R.223
- Hydrogen bonds: A:R.150, A:W.177, A:W.177, A:R.223, A:E.276, A:E.276, A:R.292, A:R.292
- Water bridges: A:R.116, A:D.149, A:R.150, A:R.154, A:E.226, A:R.374
- Salt bridges: A:R.116, A:E.117, A:D.149, A:E.226, A:R.292, A:R.374
ZMR.10: 14 residues within 4Å:- Chain B: R.116, E.117, D.149, R.150, R.154, W.177, R.223, E.226, A.245, E.275, E.276, R.292, R.374, Y.409
19 PLIP interactions:19 interactions with chain B- Hydrophobic interactions: B:D.149, B:R.150
- Hydrogen bonds: B:D.149, B:D.149, B:W.177, B:R.223, B:E.276, B:E.276, B:E.276, B:R.292, B:R.292
- Water bridges: B:R.116, B:R.154
- Salt bridges: B:R.116, B:E.117, B:D.149, B:E.226, B:R.292, B:R.374
ZMR.20: 16 residues within 4Å:- Chain C: R.116, E.117, D.149, R.150, R.154, W.177, I.221, R.223, E.226, A.245, E.275, E.276, R.292, N.294, R.374, Y.409
24 PLIP interactions:24 interactions with chain C- Hydrophobic interactions: C:W.177, C:I.221, C:R.223
- Hydrogen bonds: C:R.150, C:W.177, C:W.177, C:R.223, C:E.276, C:E.276, C:E.276, C:R.292, C:R.292, C:Y.409
- Water bridges: C:R.116, C:D.149, C:R.150, C:R.154, C:R.374
- Salt bridges: C:R.116, C:E.117, C:D.149, C:E.226, C:R.292, C:R.374
ZMR.25: 14 residues within 4Å:- Chain D: R.116, E.117, D.149, R.150, R.154, W.177, R.223, E.226, A.245, E.275, E.276, R.292, R.374, Y.409
19 PLIP interactions:19 interactions with chain D- Hydrophobic interactions: D:D.149, D:R.150
- Hydrogen bonds: D:D.149, D:D.149, D:W.177, D:R.223, D:E.276, D:E.276, D:R.292, D:R.292, D:Y.409
- Water bridges: D:R.116, D:R.154
- Salt bridges: D:R.116, D:E.117, D:D.149, D:E.226, D:R.292, D:R.374
- 14 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.6: 9 residues within 4Å:- Chain A: A.136, A.137, G.140, G.141, Y.142, Y.143
- Chain D: R.102, F.103, E.105
4 PLIP interactions:2 interactions with chain D, 2 interactions with chain A- Water bridges: D:F.103, D:E.105
- Hydrogen bonds: A:A.137, A:Y.142
EDO.7: 9 residues within 4Å:- Chain A: D.184, T.189, Y.206, G.234, C.236, I.256, R.257, E.258, G.259
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:D.184, A:E.258, A:G.259
EDO.11: 7 residues within 4Å:- Chain B: Q.93, K.94, L.455, W.456
- Chain C: D.194, L.201, K.203
6 PLIP interactions:2 interactions with chain C, 4 interactions with chain B- Hydrogen bonds: C:K.203, C:K.203, B:Q.93, B:K.94, B:L.455, B:W.456
EDO.12: 9 residues within 4Å:- Chain B: C.122, G.123, P.124, N.125, E.126, C.127, I.415, K.416
- Chain C: E.208
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:P.124, B:K.416
EDO.13: 10 residues within 4Å:- Chain A: K.94, W.456
- Chain B: N.151, K.152, L.153, R.154, A.175, A.176, W.177, D.194
4 PLIP interactions:2 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:A.176, B:A.176, A:K.94, A:K.94
EDO.14: 7 residues within 4Å:- Chain A: R.102
- Chain B: H.134, Y.142, N.144, T.146, N.151, L.153
4 PLIP interactions:3 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:H.134, B:Y.142, B:N.151, A:R.102
EDO.15: 8 residues within 4Å:- Chain B: K.299, R.300, M.317, C.318, T.319, T.321, Y.322, L.323
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:R.300, B:T.319, B:L.323
EDO.21: 9 residues within 4Å:- Chain B: R.102, F.103, E.105
- Chain C: A.136, A.137, G.140, G.141, Y.142, Y.143
4 PLIP interactions:2 interactions with chain C, 2 interactions with chain B- Hydrogen bonds: C:A.137, C:Y.142
- Water bridges: B:F.103, B:E.105
EDO.22: 9 residues within 4Å:- Chain C: D.184, T.189, Y.206, G.234, C.236, I.256, R.257, E.258, G.259
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:D.184, C:D.184, C:T.189, C:E.258, C:G.259
EDO.26: 7 residues within 4Å:- Chain A: D.194, L.201, K.203
- Chain D: Q.93, K.94, L.455, W.456
6 PLIP interactions:4 interactions with chain D, 2 interactions with chain A- Hydrogen bonds: D:Q.93, D:K.94, D:L.455, D:W.456, A:K.203, A:K.203
EDO.27: 9 residues within 4Å:- Chain A: E.208
- Chain D: C.122, G.123, P.124, N.125, E.126, C.127, I.415, K.416
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:P.124, D:K.416
EDO.28: 10 residues within 4Å:- Chain C: K.94, W.456
- Chain D: N.151, K.152, L.153, R.154, A.175, A.176, W.177, D.194
5 PLIP interactions:2 interactions with chain C, 3 interactions with chain D- Hydrogen bonds: C:K.94, C:K.94, D:A.176, D:A.176, D:D.194
EDO.29: 7 residues within 4Å:- Chain C: R.102
- Chain D: H.134, Y.142, N.144, T.146, N.151, L.153
3 PLIP interactions:1 interactions with chain C, 2 interactions with chain D- Hydrogen bonds: C:R.102, D:Y.142, D:N.151
EDO.30: 8 residues within 4Å:- Chain D: K.299, R.300, M.317, C.318, T.319, T.321, Y.322, L.323
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:R.300, D:T.319, D:L.323
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Escuret, V. et al., A Novel I221 L Substitution in Neuraminidase Confers High Level Resistance to Oseltamivir in Influenza B Viruses. J.Infect.Dis. (2014)
- Release Date
- 2014-05-14
- Peptides
- NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x CA: CALCIUM ION(Non-covalent)
- 4 x ZMR: ZANAMIVIR(Non-covalent)
- 14 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Escuret, V. et al., A Novel I221 L Substitution in Neuraminidase Confers High Level Resistance to Oseltamivir in Influenza B Viruses. J.Infect.Dis. (2014)
- Release Date
- 2014-05-14
- Peptides
- NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B